Hamdard Institute of Pharmaceutical Sciences


Hamdard Institute of Pharmaceutical Sciences has been declared as a sub-regional pharmacovigilance center for federal capital Islamabad by National Pharmacovigilance Center. The MoU was signed on 29th November 2019 between HIPS and National Pharmacovigilance Cell. As a sub-regional PV center, HIPS will conduct an assessment of the adverse drug reactions reports, which after validation, will be stored in the national database, will be involved in informing physicians and other health professionals about medicines, their risks, their use and proper use and will conduct research studies on methodology in pharmacovigilance, on the nature and mechanisms of adverse drug reactions.